MAÂT
LIVE

Serial Number

79325211

Owner

MAAT PHARMA

Attorney

Jeffrey H. Greger

Filing Date

Sep 28, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MAÂT Trademark

Serial Number: 79325211 • Registration: 7070571

MAÂT is a trademark filed by MAAT PHARMA on September 28, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MAAT PHARMA (12 trademarks)

70 avenue Tony Garnier

Entity Type: 99

Trademark Details

Filing Date

September 28, 2021

Registration Date

June 6, 2023

Published for Opposition

March 21, 2023

Goods & Services

Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for third parties; technical project studies, namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services, namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy

Pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely microbiotherapy preparations for intestinal microbiome repair; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use; culture media for bacteriology; chemico-pharmaceutical products, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for intestinal microbiome repair

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 18, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2023 FICS
FINAL DISPOSITION PROCESSED
Sep 6, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 6, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 6, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 6, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 1, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 12, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 12, 2023 OPNR
NOTIFICATION PROCESSED BY IB
Mar 21, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 1, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 1, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2023 TROA
REFUSAL PROCESSED BY IB
Aug 17, 2022 RFNP
ATTORNEY REVIEW COMPLETED
Jul 29, 2022 ATRV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 28, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 27, 2022 RFRR
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jul 27, 2022 LIME
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 1, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 30, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2022 DOCK
LIMITATION OF GOODS RECEIVED FROM IB
May 29, 2022 LIMG
APPLICATION FILING RECEIPT MAILED
Nov 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 11, 2021 REPR